Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022 EP News Bureau Dec 13, 2022 Updated data from phase-III Polarix study continue to demonstrate a statistically significant reduction in the risk of disease…
FDA accepts supplemental Biologics Licence Application for Roche’s Polivy combination EP News Bureau Aug 16, 2022 The acceptance has been given for people with previously untreated diffuse large B-cell lymphoma
CHMP recommends EU approval of Roche’s Polivy combination for people with previously untreated… EP News Bureau Mar 28, 2022 The recommendation is based on pivotal data from the phase-III Polarix study
